Short Interest in FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November (BATS:XNOV) Grows By 197.4%

FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November (BATS:XNOV) was the recipient of a large growth in short interest during the month of August. As of August 14th, there was short interest totaling 452 shares, a growth of 197.4% from the July 30th total of 152 shares. Based on an average trading volume of 2,307 shares, the short-interest ratio is presently 0.2 days. Currently, 0.1% of the company’s shares are short sold.

FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November Stock Up 0.0%

XNOV opened at $40.28 on Friday. The business has a fifty day moving average of $39.86 and a 200 day moving average of $38.98. FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November has a 52-week low of $36.11 and a 52-week high of $40.29. The stock has a market cap of $30.21 million, a P/E ratio of 24.94 and a beta of 0.24.

Institutional Trading of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November

A hedge fund recently bought a new stake in FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November stock. Arkadios Wealth Advisors bought a new stake in shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November (BATS:XNOV) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 8,548 shares of the company’s stock, valued at approximately $324,000. Arkadios Wealth Advisors owned 1.42% of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November at the end of the most recent quarter.

FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November Company Profile

The FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November (XNOV) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to outperform the SPY ETF at about 2x positive price returns while aiming for specific buffered losses and capped gains over a one-year period. The actively managed fund holds options and collateral. XNOV was launched on Nov 17, 2023 and is issued by First Trust.